Abbott Laboratories (ABT) has declared a quarterly dividend of $0.59 per share, payable to shareholders of record. The ex-dividend date is set for October 14, 2025, meaning investors must own shares before this date to qualify for the dividend payment. Shareholders will receive the dividend on November 16, 2025.
This dividend yield stands at 1.88%, reflecting the annual income relative to the stock price. Abbott Laboratories, a key player in the health care sector, engages in the discovery, development, manufacture, and sale of a broad range of healthcare products. The company operates across four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. It serves customers in over 160 countries and employs approximately 114,000 staff.
As of November 20, 2025, Abbott's market capitalization is $214.4 billion, with a price-to-earnings ratio of 15.34 and earnings per share of 8.01. The upcoming earnings report is scheduled for April 14, 2026, with an estimated EPS of $1.21 and revenue of $11.3 billion.
Such decisions reflect Abbott's commitment to returning value to shareholders through regular dividend payments, which can be appealing to income-focused investors. Investors are encouraged to consider the company's dividend history, payout ratio, and overall financial health when assessing the sustainability of these payments.